The landscape of managing diabetes is changing with the emergence of transdermal GLP-1 delivery . These innovative devices offer a potentially less invasive alternative to shots for individuals living with diabetes mellitus type 2 . Such a system deliver GLP-1 medication directly through the epidermis, bypassing the requirement for daily injections